🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Plaque Psoriasis

Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis NCT07261306EARLY Phase 11 site📍 Lahore Lahore General Hospital · Tests: Methotrexate, Tofacitinib Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea NCT06258668n/a2 sites📍 Seoul📍 Seoul Bristol-Myers Squibb · Tests: Deucravacitinib A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis NCT04772079Phase 365 sites📍 Ciudad Autonoma de Buenos Aires📍 Ciudad Autonoma de Buenos Aires📍 Buenos Aires Bristol-Myers Squibb · Tests: Deucravacitinib, Placebo matching deucravacitinib A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults NCT07233291Phase 21 site📍 Al Mansurah Ahmed Ibrahim · Tests: Oral roflumilast A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis NCT07129382Phase 1, Phase 211 sites📍 Beijing📍 Beijing📍 Chengde Chipscreen Biosciences, Ltd. · Tests: CS32582 capsule（low dose） or matched placebo, CS32582 capsule（high dose） or matched placebo, CS32582 capsule（low dose）,… A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis NCT06912165Phase 21 site📍 Nanjing Zhejiang Wenda Pharma Technology LTD. · Tests: WD-890 tablet, WD-890 tablet, WD-890 tablet, Placebo A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis NCT07038720Phase 11 site📍 Hangzhou Usynova Pharmaceuticals Ltd. · Tests: UA026, Placebo Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications NCT04846959n/a2 sites📍 Morrisville📍 Wilmington AbbVie · Tests: Risankizumab, Comparator Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis NCT07251998Phase 21 site📍 Shanghai Beijing InnoCare Pharma Tech Co., Ltd. · Tests: ICP-332 Tablets, ICP-332 Tablets, ICP-332 Tablets, ICP-332 Placebo Tablets A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis NCT06979453Phase 3133 sites📍 Birmingham📍 Birmingham📍 Phoenix Bristol-Myers Squibb · Tests: Deucravacitinib, Placebo SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) NCT07021495n/a8 sites📍 Nijmegen📍 Maastricht📍 Amsterdam Leiden University Medical Center A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period NCT07733089Phase 11 site📍 Leiden Zealand Pharma · Tests: ZP9830, Placebo Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis NCT07719530Phase 21 site📍 Guangzhou Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: The SHR-1139 injection, placebo An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis NCT07449702Phase 239 sites📍 Phoenix📍 North Little Rock📍 Fountain Valley Oruka Therapeutics, Inc. · Tests: ORKA-001 Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis NCT04537689Phase 41 site📍 Outram Park Singapore General Hospital · Tests: Ixekizumab, Methotrexate, Cyclosporin A, Acitretin ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar NCT06997055n/a1 site📍 Amiens Celltrion HealthCare France · Tests: Ustekinumab 45 mg, Ustekinumab 90 mg A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis NCT07780929NA1 site📍 Xi'an Xijing Hospital · Tests: XJH05 ointment, Calcipotriol ointment Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) NCT07611747Phase 417 sites📍 Alicante📍 Elche📍 Orihuela Instituto de Investigación Marqués de Valdecilla · Tests: Carotid Ultrasound, High-intensity lipid-lowering therapy, Standard care according to ESC 2021 guidelines A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis NCT06030076n/a1 site📍 Graz Almirall, S.A. · Tests: Tildrakizumab Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis NCT06696417n/a1 site📍 Shenyang First Hospital of China Medical University · Tests: Drug group：vunakizumab (IL-17A inhibitor) A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis NCT07265284Phase 31 site📍 Beijing Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Tests: IBI112, placebo Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms NCT06786936n/a1 site📍 Glasgow NHS Greater Glasgow and Clyde · Tests: Secukinumab, Bimekizumab, Ixekizumab, Placebo A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis NCT07250802Phase 339 sites📍 Chula Vista📍 Fountain Valley📍 Hialeah Takeda · Tests: Zasocitinib, Placebo, Zasocitinib A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis NCT07326813Phase 31 site📍 Shanghai InventisBio Co., Ltd · Tests: D-2570 Tablet, BMS-986165 Tablet, Placebo Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis. NCT07410793Phase 21 site📍 Muang Mae Fah Luang University · Tests: Acupuncture, Calcipotriol 0.005% ointment, Chinese herb cream Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis NCT07130604Phase 31 site📍 Beijing InventisBio Co., Ltd · Tests: D-2570, Placebo Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation? NCT06742333Phase 27 sites📍 Nice📍 Lyon📍 Marseille Centre Hospitalier Universitaire de Nice · Tests: Bimekizumab, Clobetasol A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis NCT07234591NA1 site📍 Shanghai Usynova Pharmaceuticals Ltd. · Tests: Tyk2 inhibitor, Placebo Serum Substance P, Neuropathic Pain, and Central Sensitization Across Treatment Groups in Chronic Plaque Psoriasis NCT07844772n/a1 site📍 Istanbul Istanbul Training and Research Hospital · Tests: IL-17 Inhibitor Therapy, Conventional Systemic Therapy A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD NCT07683065n/a7 sites📍 Badalona📍 Barcelona📍 Barcelona Novartis Pharmaceuticals
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy